Update on CARTITUDE-1: CAR-T in RRMM
Jesus Berdeja, MD, Director of Myeloma Research, Sarah Cannon Research Institute, Nashville, TN, gives an update on CARTITUDE-1 (NCT03548207), a…
Jesus Berdeja, MD, Director of Myeloma Research, Sarah Cannon Research Institute, Nashville, TN, gives an update on CARTITUDE-1 (NCT03548207), a…
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve…
Clonal hematopoiesis of indeterminate potential (CHIP) and clonal cytopenia of unknown significance (CCUS) are considered precursor diseases to hematologic malignancies,…
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve…
Welcome to The Myeloma Sessions brought to you by the Video Journal of Hematology and Hematological Oncology (VJHemOnc). These exclusive sessions feature roundtable discussions from…
In association with our world-leading Editorial Board, VJHemOnc bring you the latest updates in multiple myeloma, directly from the experts.
Welcome to The MDS Sessions brought to you by the Video Journal of Hematology and Hematological Oncology (VJHemOnc). This exclusive discussion features leading experts Amer…
In this video, Anna Sureda, MD, PhD, Catalan Institute of Oncology, Duran I Reynals Hospital, Barcelona, Spain, shares details of the 50th Annual Meeting of…
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve…
Daniel Addison, MD, The Ohio State University Wexner Medical Center, Columbus, OH, discusses a large-scale post-marketing surveillance study that aimed to identify safety signals and…
Caner Saygin, MD, University of Chicago, Chicago, IL, discusses a study investigating the role of myeloid mutations in therapy-related acute lymphoblastic leukemia (ALL). This study…